Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Urologic Neoplasms × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 35 Neoplasms 33 Depression 23 Fatigue 21 Prostatic Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Multiple Myeloma 13 Lymphoma, Follicular 13 Carcinoma, Non-Small-Cell Lung 12 Pain 11 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, B-Cell, Marginal Zone 10 Lung Neoplasms 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Colorectal Neoplasms 10 Burkitt Lymphoma 10 Anxiety Disorders 10 Lymphoma, Large-Cell, Immunoblastic 9 Vomiting 8 Nausea 8 Leukemia, Myeloid, Chronic-Phase 8 Leukemia, Myeloid, Acute 8 Hodgkin Disease 8 Blast Crisis 8 Lymphoma, T-Cell, Cutaneous 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia, Hairy Cell 7 Carcinoma, Ovarian Epithelial 7

Interventions

Gemcitabine 7 pembrolizumab 4 atezolizumab 3 Trastuzumab 3 Sunitinib 3 Carboplatin 3 enfortumab vedotin 2 cabozantinib 2 Water 2 Standard of Care 2 Pemetrexed 2 Paclitaxel 2 Cisplatin 2 Cetuximab 2 Bevacizumab 2 vinflunine 1 valrubicin 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 poly ICLC 1 niraparib 1 montanide ISA 51 1 lenvatinib 1 flt3 ligand protein 1 dodecyl maltoside 1 daratumumab 1 avelumab 1 abemaciclib 1 Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡